PNS for Vascular Function and Limb Health in Veterans

This study is looking at how a treatment called Peripheral Nerve Stimulation (PNS) can help improve blood flow and overall limb health in Veterans. It's also testing a new way to measure nerve and blood vessel health using an implanted device. You might be able to join if you are a Veteran with diabetes and nerve damage (diabetic peripheral neuropathy) or if you've had a lower limb amputation. The researchers want to see if PNS can improve how well your blood vessels respond and increase blood flow to your skin. This could help prevent skin problems and further limb issues. The study aims to enroll 42 participants, but its current status is unclear.

Study design
This is an interventional study planning to enroll 42 participants. It will test two types of devices: a Chronically Implanted Neural and Muscular Interface and a Peripheral Nerve Stimulation (PNS) interface.
What's involved
You would have visits for about one year, with measurements taken at baseline and then at visits 1-15. These measurements include checking your skin's blood flow, vessel density, and tissue oxygen levels.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for approximately one year, with measurements taken until study completion.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07696988

PNS to Improve Vascular Function and Limb Health in Veterans

Not Yet Recruiting
NAAges 18+InterventionalHealth services
VA Office of Research and Development
~42 participants
Updated 2026-07-10 on ClinicalTrials.gov
What's tested:Chronically Implanted Neural and Muscular InterfacePeripheral Nerve Stimulation (PNS)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cutaneous Vascular Conductance
Measured over baseline and visits 1-15 until study completion, average 1 year
+4 more outcomes measured
Lower Limb Amputees
Diabetes
1 sites across 1 states
Ohio1
  • Hamid Charkhkar, PhD · PRINCIPAL_INVESTIGATOR · Louis Stokes VA Medical Center, Cleveland, OH

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English-speaking
Confirmed diagnosis of type 1 or type 2 diabetes mellitus for at least 5 years
Clinical signs and/or symptoms consistent with diabetic peripheral neuropathy Or confirmation of neuropathy via physical exam
Unilateral transtibial or transfemoral amputation
Medically stable for at least 3 months
For the designated subset of the limb-loss cohort (n = 6): implanted with C-FINEs on the sciatic and/or tibial nerves

Exclusion

Severe neurological disorders impairing ambulation
Visual or hearing impairments interfering with study participation
Cardiovascular or respiratory conditions posing risk during participation
Cognitive or psychiatric conditions compromising informed consent
Participation in other clinical trials interfering with outcomes
Pregnancy
History of photosensitivity or known sensitivity to laser light
Active skin breakdown or infection at residual limb
Significant phantom or residual limb pain interfering with study procedures
Bilateral lower-limb amputation
  • Cutaneous Vascular Conductancebaseline and visits 1-15 until study completion, average 1 year

    Autonomic reflex testing including thermal axon reflex and pressure induced vasoconstriction will be applied. The cutaneous blood flow in the lower limb will be measured using laser doppler flowmetry. The flux is divided by mean arterial pressure to calculate cutaneous vascular conductance. This provides a physiologically relevant metric of microvascular control by accounting for systemic pressure fluctuations

  • Vessel Densitybaseline and visits 1-15 until study completion, average 1 year

    Defined as the percentage of tissue volume occupied by vascular structures. The investigators use photoacoustic imaging of microvascular structure to quantify microvascular structural integrity at distal and proximal skin sites. From the reconstructed volumetric data, the investigators will extract the vessel density

  • Tissue Oxygen Saturationbaseline and visits 1-15 until study completion, average 1 year

    Tissue oxygen saturation or sO2 will be measured during different conditions of the study such as thermal axon reflex and pressure induced vasoconstriction using reflectance spectroscopy

  • Mean Vessel Diameterbaseline and visits 1-15 until study completion, average 1 year

    Calculated from the cross-sectional profiles of resolved vessels obtained from the photoacoustic imaging of microvascular structures

  • Hemoglobin Oxygenationbaseline and visits 1-15 until study completion, average 1 year

    From photoacoustic imaging, hemoglobin oxygenation is derived and compared across different study conditions